Viking Therapeutics surged more than 26% on fresh GLP-1 maintenance data while every major obesity peer from Eli Lilly to Novo Nordisk barely registered a pulse, raising a pointed question about whether this catalyst…
A buried IRS rule lets you move depressed shares into a Roth without selling, locking in a lower tax bill before the rebound arrives. But one irreversible mistake can leave you paying taxes on…
Cisco is sliding 6% while its closest networking rivals barely flinch and the broader tech sector actually gains ground, and no company announcement explains why the stock is moving alone.
A week in Western Europe can drain a vacation budget before you even book a single tour, but some countries still let you stretch every dollar surprisingly far. These 15 destinations span four continents…
Washington just handed silver a designation that lithium and cobalt already carry, and the fallout for stock investors is more complicated than the headlines suggest. Knowing what the label actually triggers changes how much…
AutoZone's latest quarter split the market in two directions at once, and the ripple through its rivals says something surprising about how traders are reading the aftermarket retail group right now.
A small-cap silicon photonics company has quietly built a cash fortress and locked in a major anchor customer, positioning itself to compete in a $26 billion AI optics market where the giants are not…
JPMorgan Chase just landed a $20 billion sovereign wealth partnership, yet its stock is leading the big banks lower today. Something bigger than a press release is moving the tape, and it starts with…
GE Vernova's backlog keeps exploding and its CEO says the company will be mostly sold out through 2030, yet most AI power investors are looking at entirely the wrong part of the supply chain.